# Fluxa Ventures

Investor in Kirkland, Washington

## About Fluxa Ventures

Fluxa Ventures is a hybrid VC–Studio engine that turns frontier ideas into global-ready companies. Proudly founded by Turkish engineers and entrepreneurs with backgrounds in leading U.S. tech giants.

Fluxa Ventures builds and backs frontier technology companies. We operate as a unified Venture Capital fund and Venture Studio. This dual engine allows us to identify meaningful market gaps early, build rapid MVPs, validate revenue fast, and fund the strongest ideas.

Our Studio creates new startups from concept to spin-off. Our Capital arm invests in external founders with high technical depth and clear scale potential. Together, they form an integrated venture platform that reduces early-stage risk and accelerates company creation.

We focus on Energy Management Technologies, Quantum Technologies, and AI-Driven Technologies.

Fluxa is built by operators, engineers, and global founders who combine product execution with strategic capital. We partner with ambitious founders and enterprises looking to build or scale transformative technologies.

## People

- **Dincer Keskinpala**, Co-Founder

## Key Facts

- **Location:** Kirkland, Washington
- **Investor Type:** Venture Capital
- **Founded:** 2025

## Investment Industries

- Artificial Intelligence (AI)
- Energy
- Technology/Web/App

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/fluxa-ventures
- More investors: [AI Investors in Washington](https://askforfunding.com/site/angel-investors/washington/ai)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
